Getinet M. Adinew, a native of Gondar, Ethiopia, has achieved a remarkable feat in his academic career by earning multiple degrees and accolades in pharmaceutical science. In 2009, he obtained a Bachelor of Science (B.S.) in pharmacy from the University of Gondar, Ethiopia, followed by a Master of Science (M.S.) in Pharmacology in 2013.
In 2019, Getinet joined the Pharmaceutical Science Doctoral Program, specializing in Pharmacology/Toxicology at Florida A&M University. During his time at the university, he earned his second M.S. in Pharmaceutical Sciences in the summer of 2022 while also being involved in supervised teaching for the Bachelor of Science in Pharmaceutical Sciences (BSPS) program at the FAMU College of Pharmacy and Pharmaceutical Science, Institute of Public Health.
Throughout his studies at FAMU, Getinet remained focused on his research in the anticancer role of thymoquinone. His work involved the alteration of apoptotic gene expression, cell cycle arrest, and modulations of Nrf2/ ARE/PD-L1 in triple-negative breast cancer, and has resulted in the publication of ten articles and one book chapter, all of which he served as a first author.
Getinet's impressive accomplishments have not gone unnoticed. In April 2022, he received the Kamala Kaur Award for Excellence in Research and garnered high praise and accolades from his peers and the Awards Ceremonies committee for his excellence in academics and publication record.
Getinet's journey culminated in his successful defense of his dissertation on January 26, 2023, marking the end of his studies at FAMU. His remarkable achievements within the last three years serve as an inspiration for other graduate students, and his success demonstrates the importance of dedication, hard work, and perseverance. Getinet's academic and research accomplishments have placed him in an elite group of Ph.D. students, and his story is a testament to the transformative power of education.